MedicineWorld.Org
Your gateway to the world of medicine
Home
News
Cancer News
About Us
Cancer
Health Professionals
Patients and public
Contact Us
Disclaimer

Medicineworld.org: FDG-PET Has Major Impact on Cancer Patient Care

Back to cancer blog Blogs list Cancer blog  


Subscribe To Cancer Blog RSS Feed  RSS content feed What is RSS feed?

FDG-PET Has Major Impact on Cancer Patient Care




As per a research studyof data from the National Oncologic PET Registry (NOPR) published online in the Journal of Clinical Oncology (JCO) on March 24th, clinicians changed the intended care of more than one in three cancer patients as the results of FDG-PET scan findings.

There were over 1500 participating facilities that contributed FDG-PET scan data from the nearly 23,000 patients involved in the study. Analysis of registry data published in the JCO article observed that FDG-PET is linked to a 36.5% change in the therapy or no-treatment decision.

SNM, the world's largest molecular imaging and nuclear medicine society, has been a great supporter of the NOPR since it's inception nearly two years ago and is excited to see this promising data released.



FDG-PET Has Major Impact on Cancer Patient Care
CT PET scannner

The NOPR was launched in May 2006 in response to the Center for Medicare and Medicaid Services' (CMS) novel "Coverage with Evidence" policy to collect data through a clinical registry to inform the center's FDG-PET coverage determination decisions for currently non-covered cancer indications. Sponsored by the Academy of Molecular Imaging (AMI) and managed by the American College of Radiology (ACR) and the ACR Imaging Network (ACRIN), the NOPR is designed to collect questionnaire data from referring physicians on intended patient management before and after a FDG-PET scan.

In response to this positive data, NOPR has formally asked CMS to reconsider the current National Coverage decision on FDG-PET to end the data collection requirements for diagnosis, staging and restaging. CMS will then review the data and issue their decision regarding reimbursement for PET scans covered only through the NOPR.

The authors think that "the data collected by NOPR fulfils an unmet need with its primary scientific aim of measuring the impact of PET on patient management in a manner that is minimally intrusive to care providers." They also state that "our findings are representative of Medicare patients for whom PET would be ordered if it were covered by CMS for the expanded indications".

FDG-PET, also called PET imaging or PET scan, is a test that images the function of cells to show differences between healthy tissue and diseased tissue. It uses a small amount of a radioactive chemical which is combined with sugar. This combination is called FDG, so the test is sometimes called an FDG-PET scan. It is used to evaluate various neurological and cardiac disorders, as well as for diagnosing, staging, and monitoring the therapy of a number of different cancers.


Posted by: Janet    Source




Did you know?
As per a research studyof data from the National Oncologic PET Registry (NOPR) published online in the Journal of Clinical Oncology (JCO) on March 24th, clinicians changed the intended care of more than one in three cancer patients as the results of FDG-PET scan findings. There were over 1500 participating facilities that contributed FDG-PET scan data from the nearly 23,000 patients involved in the study. Analysis of registry data published in the JCO article observed that FDG-PET is linked to a 36.5% change in the therapy or no-treatment decision.

Medicineworld.org: FDG-PET Has Major Impact on Cancer Patient Care

Main Page| Cancer blog| Cancer blogs list| Lung cancer blog| Colon cancer blog| Prostate cancer blog| Breast cancer blog| Diabetes watch blog| Heart watch blog| Allergy blog| Bladder cancer blog| Cervical cancer blog| Colon cancer news blog| Diabetes news blog| Esophageal cancer blog| Gastric cancer blog| Health news blog| Heart news blog| Infectious disease blog| Kidney watch blog| Lung disease blog| Lung cancer news blog| Mesothelioma blog| Neurology blog| Breast cancer news blog| OBGYN blog| Ophthalmology blog| Ovarian cancer blog| Cancer news blog| Pancreas cancer blog| Pediatrics blog| Prostate cancer news blog| Psychology blog| Research blog| Rheumatology blog| Society news blog| Uterine cancer blog| Weight watch blog|

Copyright statement
The contents of this web page are protected. Legal action may follow for reproduction of materials without permission.